Brief: Acer Therapeutics Posts Q4 Loss Per Share Of $0.31
02/03/2022 22:21
March 2 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS REPORTS Q4 AND FULL YEAR 2021 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q4 LOSS PER SHARE $0.31
Source text for Eikon: ID:nGNX7pVCms
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31